These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31174096)

  • 1. Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy.
    Techatanawat S; Surarit R; Chairatvit K; Roytrakul S; Khovidhunkit W; Thanakun S; Izumi Y; Khovidhunkit SP
    Arch Oral Biol; 2019 Aug; 104():67-75. PubMed ID: 31174096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.
    Talungchit S; Buajeeb W; Lerdtripop C; Surarit R; Chairatvit K; Roytrakul S; Kobayashi H; Izumi Y; Khovidhunkit SP
    BMC Oral Health; 2018 Mar; 18(1):42. PubMed ID: 29534707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of periodontal treatment on the protein composition of whole and parotid saliva.
    Henskens YM; van der Weijden FA; van den Keijbus PA; Veerman EC; Timmerman MF; van der Velden U; Amerongen AV
    J Periodontol; 1996 Mar; 67(3):205-12. PubMed ID: 8708950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cystatin C levels are associated with asymptomatic peripheral arterial disease in type 2 diabetes mellitus patients without overt nephropathy.
    Huh JH; Choi E; Lim JS; Lee MY; Chung CH; Shin JY
    Diabetes Res Clin Pract; 2015 May; 108(2):258-64. PubMed ID: 25743114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Dejenie TA; Abebe EC; Mengstie MA; Seid MA; Gebeyehu NA; Adella GA; Kassie GA; Gebrekidan AY; Gesese MM; Tegegne KD; Anley DT; Feleke SF; Zemene MA; Dessie AM; Moges N; Kebede YS; Bantie B; Adugna DG
    Front Endocrinol (Lausanne); 2023; 14():1124367. PubMed ID: 37082121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.
    Jeon YL; Kim MH; Lee WI; Kang SY
    Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Elsayed MS; El Badawy A; Ahmed A; Omar R; Mohamed A
    Diabetes Metab Syndr; 2019; 13(1):374-381. PubMed ID: 30641728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
    Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of Renal Function in Type 2 Diabetic Patients with Cognitive Impairment.
    Zhang JB; Geng N; Li ZG; Qiao HJ; Sun HR; Li F
    Neurosci Lett; 2016 Jan; 610():19-23. PubMed ID: 26520462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Glucose/C-Peptide Ratio and the Risk of Disease Progression in Diabetic Nephropathy Patients: A Clinical Retrospective Analysis.
    Tong H; Wang D; Fang M
    J Healthc Eng; 2022; 2022():7406764. PubMed ID: 35399828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
    Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
    Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.
    Shimizu A; Horikoshi S; Rinnno H; Kobata M; Saito K; Tomino Y
    J Clin Lab Anal; 2003; 17(5):164-7. PubMed ID: 12938144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.